Home > products > custom-nanocomposites
> nanopeptides
> nintedanib-and-dexamethasone-liposomal-cy5-5-100-150nm
Nintedanib and Dexamethasone@Liposomal CY5.5,100-150nm
Liposome loaded with Nintedanib and Dexamethasone modified CY5.5
Product description
Nintedanib and Dexamethasone@Liposomal CY5.5,100-150nm/Liposome@with Nintedanib and Dexamethasone modified CY5.5 is a multifunctional targeted nano delivery system that achieves synergistic anti fibrotic and anti-inflammatory effects through liposome encapsulated dual drugs, and uses CY5.5 near-infrared fluorescence labeling to achieve real-time visualization tracking of in vivo distribution. It is mainly used for the study of acute exacerbation of pulmonary fibrosis (AE-IPF) or tumor related fibrosis microenvironment.
| Appearance | Freeze-dried powder |
|---|---|
| Size | 100-150nm |
| Solubility | N/A |
| Drug loading | 4.2%(Nintedanib); 0.85%(Dexamethasone) |
| Encapsulation efficiency | 91.3%(Nintedanib); 93.3%(Dexamethasone) |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 1-3 weeks |
| Stability | 6 months |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of Nintedanib and Dexamethasone@Liposomal CY5.5,100-150nm
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


